Background
Titles
- Co-Director of Clinical and Epidemiological Research, Lyme Disease Research Center
- Instructor of Medicine
Departments / Divisions
Centers & Institutes
- Lyme Disease Clinical Research Center
Acute and post-treatment Lyme disease; Sex and gender-based differences in health; Illness experience of medically contested conditions ...read more
Alison Rebman is currently engaged in both quantitative and qualitative research that seeks to understand the epidemiology, risk factors, and patient illness experience of post-treatment Lyme disease.
Rebman AW, Aucott JN, Weinstein ER, Bechtold KT, Smith KC, Leonard L. Living in limbo: contested narratives of patients with chronic symptoms following Lyme disease. Qual Health Res. 2017:27(4):534-546. PMID: 26631681
Rebman AW, Bechtold KT, Yang T, Mihm EA, Soloski MJ, Novak CB, Aucott JN. The clinical, symptom, and quality-of-life characterization of a well-defined group of patients with post-treatment Lyme disease syndrome. Front Med (Lausanne). 2017:4:224. PMCID: PMC5735370
Rebman AW, Wang L, Yang T, Marsteller JA, Murphy SME, Uriyo M, Mihm EA, Weinstein ER, Fagan P, Aucott JN. Incidence of Lyme disease diagnosis in a Maryland Medicaid population (2004-2011). Am J Epidemiol. 2018:187(10):2202-2209. PMID: 29955850
Aucott JN, Rebman AW. Long-haul COVID: heed the lessons from other infection-triggered illnesses. The Lancet. 2021:397(10278):967-968. PMCID: PMC7952095
Aucott JN, Yang T, Yoon I, Powell D, Geller SA, Rebman AW. Risk of post-treatment Lyme disease in patients with ideally treated Lyme disease: A prospective cohort study. IJID 2022:116;230-237. PMID: 35066160
Patient Ratings & Comments
The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.